News
Despite new market entrants in the form of Gilead's Livdelzi and Ipsen's Iqirvo, US gastroenterologists report nearly half of PBC patients suffer fro ...
Union trustees allege health plan documents didn’t allow for $4.3 million in drug spending that was cleared by pharmacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results